DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Andus T, Kocjan A, Muser M. et al.
Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
Inflamm Bowel Dis 2010;
16: 1947-1956
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.